Sandoz Slashes Glatiramer Price In US

Glatopa Brand Around A Quarter Of Copaxone List Price

Sandoz has cut its US wholesale price for its Glatopa glatiramer acetate brand by more than 70% to offer a substantial difference to both Teva’s Copaxone reference brand and Mylan’s generic.

Price cut
Sandoz has slashed the list price of its glatiramer acetate generic in the US by more than 70% • Source: Shutterstock

Sandoz has cut by over 70% the wholesale acquisition cost of its Glatopa (glatiramer acetate) 20mg/ml and Glatopa 40mg/ml pre-filled syringes in the US.

More from Drug Pricing

More from Policy & Regulation